It is expected that its modern form of collection, storage and interpretation of genomic data may allow an advance in the development and research within the private sector, mainly in terms of the development of drugs of various types and molecular treatments that are part of advanced medicine , also called precision medicine, which includes the modern genomic risk diagnoses that make it easier to know the chances of an individual suffering from some type of cancer. This is thanks to the fact that truly high participation numbers are handled, so it is to be expected that when Shivom enters fully into its operations, it will be the first to collect and study a massive number of specific genomic data in fields of cellular aging and grouping of rare genomes, which will allow in the next few years to see how it grows possibly the largest genomic library of rare genes in the world.
You are viewing a single comment's thread from: